Microvascular decompression for treating hemifacial spasm: Lessons learned from a prospective study of 1,174 operations

Seong Jae Hyun, Doo Sik Kong, Kwan Park

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The authors critically analyzed a large series of patients with hemifacial spasm (HFS) and who underwent microvascular decompression (MVD) under a prospective protocol. We describe several "lessons learned" that are required for achieving successful surgery and proper postoperative management. The purpose of this study is to report on our experience during the previous 10 years with this procedure and we also discuss various related topics. From April 1997 to June 2009, over 1,200 consecutive patients underwent MVD for HFS. Among them, 1,174 patients who underwent MVD for HFS with a minimum 1 year follow-up were enrolled in the study. The median follow-up period was 3.5 years (range, 1-9.3 years). Based on the operative and medical records, the intraoperative findings and the postoperative outcomes were obtained and then analyzed. At the 1-year follow-up examination, 1,105 (94.1%) patients of the total 1,174 patients exhibited a "cured" state, and 69 (5.9%) patients had residual spasms. In all the patients, the major postoperative complications included transient hearing loss in 31 (2.6%), permanent hearing loss in 13 (1.1%), transient facial weakness in 86 (7.3%), permanent facial weakness in 9 (0.7%), cerebrospinal fluid leak in three (0.25%) and cerebellar infarction or hemorrhage in two (0.17%). There were no operative deaths. Microvascular decompression is a very effective, safe modality of treatment for hemifacial spasm. MVD is not sophisticated surgery, but having a basic understanding of the surgical procedures is required to achieve successful surgery.

Original languageEnglish
Pages (from-to)325-334
Number of pages10
JournalNeurosurgical Review
Volume33
Issue number3
DOIs
StatePublished - 1 Jul 2010

Fingerprint

Microvascular Decompression Surgery
Hemifacial Spasm
Prospective Studies
Hearing Loss
Spasm
Infarction
Medical Records
Hemorrhage

Keywords

  • Hemifacial spasm
  • Lessons
  • Microvascular decompression
  • Neurophysiological monitoring
  • Outcome

Cite this

@article{5de402476bbc4c4bbef4b231525a0c81,
title = "Microvascular decompression for treating hemifacial spasm: Lessons learned from a prospective study of 1,174 operations",
abstract = "The authors critically analyzed a large series of patients with hemifacial spasm (HFS) and who underwent microvascular decompression (MVD) under a prospective protocol. We describe several {"}lessons learned{"} that are required for achieving successful surgery and proper postoperative management. The purpose of this study is to report on our experience during the previous 10 years with this procedure and we also discuss various related topics. From April 1997 to June 2009, over 1,200 consecutive patients underwent MVD for HFS. Among them, 1,174 patients who underwent MVD for HFS with a minimum 1 year follow-up were enrolled in the study. The median follow-up period was 3.5 years (range, 1-9.3 years). Based on the operative and medical records, the intraoperative findings and the postoperative outcomes were obtained and then analyzed. At the 1-year follow-up examination, 1,105 (94.1{\%}) patients of the total 1,174 patients exhibited a {"}cured{"} state, and 69 (5.9{\%}) patients had residual spasms. In all the patients, the major postoperative complications included transient hearing loss in 31 (2.6{\%}), permanent hearing loss in 13 (1.1{\%}), transient facial weakness in 86 (7.3{\%}), permanent facial weakness in 9 (0.7{\%}), cerebrospinal fluid leak in three (0.25{\%}) and cerebellar infarction or hemorrhage in two (0.17{\%}). There were no operative deaths. Microvascular decompression is a very effective, safe modality of treatment for hemifacial spasm. MVD is not sophisticated surgery, but having a basic understanding of the surgical procedures is required to achieve successful surgery.",
keywords = "Hemifacial spasm, Lessons, Microvascular decompression, Neurophysiological monitoring, Outcome",
author = "Hyun, {Seong Jae} and Kong, {Doo Sik} and Kwan Park",
year = "2010",
month = "7",
day = "1",
doi = "10.1007/s10143-010-0254-9",
language = "English",
volume = "33",
pages = "325--334",
journal = "Neurosurgical Review",
issn = "0344-5607",
publisher = "Springer Verlag",
number = "3",

}

Microvascular decompression for treating hemifacial spasm : Lessons learned from a prospective study of 1,174 operations. / Hyun, Seong Jae; Kong, Doo Sik; Park, Kwan.

In: Neurosurgical Review, Vol. 33, No. 3, 01.07.2010, p. 325-334.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microvascular decompression for treating hemifacial spasm

T2 - Lessons learned from a prospective study of 1,174 operations

AU - Hyun, Seong Jae

AU - Kong, Doo Sik

AU - Park, Kwan

PY - 2010/7/1

Y1 - 2010/7/1

N2 - The authors critically analyzed a large series of patients with hemifacial spasm (HFS) and who underwent microvascular decompression (MVD) under a prospective protocol. We describe several "lessons learned" that are required for achieving successful surgery and proper postoperative management. The purpose of this study is to report on our experience during the previous 10 years with this procedure and we also discuss various related topics. From April 1997 to June 2009, over 1,200 consecutive patients underwent MVD for HFS. Among them, 1,174 patients who underwent MVD for HFS with a minimum 1 year follow-up were enrolled in the study. The median follow-up period was 3.5 years (range, 1-9.3 years). Based on the operative and medical records, the intraoperative findings and the postoperative outcomes were obtained and then analyzed. At the 1-year follow-up examination, 1,105 (94.1%) patients of the total 1,174 patients exhibited a "cured" state, and 69 (5.9%) patients had residual spasms. In all the patients, the major postoperative complications included transient hearing loss in 31 (2.6%), permanent hearing loss in 13 (1.1%), transient facial weakness in 86 (7.3%), permanent facial weakness in 9 (0.7%), cerebrospinal fluid leak in three (0.25%) and cerebellar infarction or hemorrhage in two (0.17%). There were no operative deaths. Microvascular decompression is a very effective, safe modality of treatment for hemifacial spasm. MVD is not sophisticated surgery, but having a basic understanding of the surgical procedures is required to achieve successful surgery.

AB - The authors critically analyzed a large series of patients with hemifacial spasm (HFS) and who underwent microvascular decompression (MVD) under a prospective protocol. We describe several "lessons learned" that are required for achieving successful surgery and proper postoperative management. The purpose of this study is to report on our experience during the previous 10 years with this procedure and we also discuss various related topics. From April 1997 to June 2009, over 1,200 consecutive patients underwent MVD for HFS. Among them, 1,174 patients who underwent MVD for HFS with a minimum 1 year follow-up were enrolled in the study. The median follow-up period was 3.5 years (range, 1-9.3 years). Based on the operative and medical records, the intraoperative findings and the postoperative outcomes were obtained and then analyzed. At the 1-year follow-up examination, 1,105 (94.1%) patients of the total 1,174 patients exhibited a "cured" state, and 69 (5.9%) patients had residual spasms. In all the patients, the major postoperative complications included transient hearing loss in 31 (2.6%), permanent hearing loss in 13 (1.1%), transient facial weakness in 86 (7.3%), permanent facial weakness in 9 (0.7%), cerebrospinal fluid leak in three (0.25%) and cerebellar infarction or hemorrhage in two (0.17%). There were no operative deaths. Microvascular decompression is a very effective, safe modality of treatment for hemifacial spasm. MVD is not sophisticated surgery, but having a basic understanding of the surgical procedures is required to achieve successful surgery.

KW - Hemifacial spasm

KW - Lessons

KW - Microvascular decompression

KW - Neurophysiological monitoring

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=77956461359&partnerID=8YFLogxK

U2 - 10.1007/s10143-010-0254-9

DO - 10.1007/s10143-010-0254-9

M3 - Article

C2 - 20349099

AN - SCOPUS:77956461359

VL - 33

SP - 325

EP - 334

JO - Neurosurgical Review

JF - Neurosurgical Review

SN - 0344-5607

IS - 3

ER -